GSK's Omjjara Authorized in EU for Treating Myelofibrosis Wi

By Joe Hoppe


GSK said its Omjjara medicine for the treatment of splenomegaly--an enlarged spleen--or symptoms in adult myelofibrosis patients with moderate to severe anemia has been authorized...

Related Keywords

United Kingdom , British , Nina Mojas , Joe Hoppe , European Commission , European Union , Dow Jones , Markets ,